[1] |
GUO Wen, DENG Zhijian, ZHANG Yongheng, GUO Jinhui.
One Case of Atrial Fibrillation Caused by Terazosin Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 580-582.
|
[2] |
LIU Weiting, WEI Wei, YANG Yanbiao.
One Case of Abnormal Elevation of International Normalized Ratio Caused by Simultaneous Application of Sodium Warfarin Tablets and Aescuven Forte Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 586-588.
|
[3] |
WU Shiqi, SU Su, YAN Suying, ZHANG Qingxia.
Bleeding Induced by Rivaroxaban Combined with PK-DDI in Patients with Nonvalvular Atrial Fibrillation and Renal Insufficiency:a Retrospective Cohort Study
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 415-419.
|
[4] |
YANG Caihua, YANG Longna, LI Xiaobo.
Two cases of fetal malformation after exposure to low dose warfarin sodium tablets in early pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1286-1289.
|
[5] |
ZHANG Wenwen, NIE Xiting, XU Huiru, RAN Ye, TIAN Chenglin, YU Shengyuan.
One case of extremely abnormal coagulation caused by warfarin combined with compound paracetamol and amantadine hydrochloride tablets
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1290-1292.
|
[6] |
LIU Tiantian, CAO Junling, ZHANG Yanli, GONG Ying, GU Yuanyuan.
Research progress in enhancing anticoagulant effects of warfarin and the mechanism by traditional Chinese medicine for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 117-120.
|
[7] |
WEN Dusu, SUN Jianjun, WANG Yi.
Safety and efficacy of participation of pharmacists in warfarin anticoagulation therapy:a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1009-1014.
|
[8] |
XIANG Yunxia, PU Wen, LI Dongfeng, WANG Jie.
Effects of pharmacists' intervention on anticoagulant management of patients treated with warfarin after heart valve replacement
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 545-549.
|
[9] |
CHAI Xiaoli, ZHANG Chen, FENG Qingchun, LIU Huan.
Current medications and influencing factors for senile patients with NVAF
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 302-305.
|
[10] |
GUO Jun, REN Dan, YE Long, ZHAO Rongxiang, WANG Yu, YU Jing.
Spontaneous muscular hemorrhage induced by warfarin tablets in a child
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 339-341.
|
[11] |
JIANG Ruiqi, MEI Shenghui, ZHAO Zhigang.
Research progress in influence of gender difference on drug therapy of common chronic diseases of the cardiovascular system
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1145-1148.
|
[12] |
WU Ting, LYV Xiaoqin.
Drug-induced Liver Injury Caused by Warfarin
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(4): 365-367.
|
[13] |
DONG Min, ZOU Tong, XU Lei, HE Qinghua, PEI Zuowei, WANG Fang.
Effects of Polypharmacy on Long-term Prognosis of Elderly Patients with Coronary Heart Disease and Atrial Fibrillation
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 126-132.
|
[14] |
LI Yu, FAN Huihui, FENG Xiaojun, WANG Yunhong, CHEN Chuantao, ZHANG Lei.
Individualized Anticoagulant Therapy for Warfarin in a Patient with Poor Metabolism
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 939-942.
|
[15] |
BAI Hehe, NIE Xiaojing, XIA Li, ZHAO Meng, WANG Jinping, YAO Yanqin.
Analysis of One Case of Warfarin Related Nephropathy
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 934-938.
|